	pharmacontrol phar o uires revco unit pharmacontrol corp said it uired private formulations inc from revco d s inc for six mln dlrs in cash a dlr promissory note and warrants to buy pharmacontrol common shares pharmacontrol said the purchase price was financed along with one mln dlrs in working capital through secured institutional financing the company said betweenm dlrs and dlrs f the principal amount of the revco note plus accrued interest is payable june the balance is payable over three years pharmacontrol said it expects to make the payment due to revco from proceeds of a proposed offering of units consisting of convertible subordinated debenturers and common stock currently on file with the securities and exchange commission upon closing of the public offering the company said it expects the secured institutional financing to increase to a total of mln dlrs private formulations is primarily engaged in the manufacture and distribution of vitamins and private label over the counter pharmaceutical products reuter 
